spacer
home > epc > spring 2002 > industry-specific supply chain software - the sugar that helps the medicine go down
PUBLICATIONS
European Pharmaceutical Contractor

Industry-Specific Supply Chain Software - The Sugar that Helps the Medicine Go Down

Matters such as meeting institutional requirements,item restrictions, traceability, speed and accuracy, storage, despatch, customer service, are very specific needs for the pharmaceutical industry, and the number one deliverables for any pharmaceutical company looking for software. For pharmaceutical distribution there is the added challenge of incredibly large transactions volumes coupled with demanding time constraints.
Pharmaceutical distribution is among the most advanced areas within distribution and supply chain management. It is only recently that integrated software covering the full spectrum of the pharmaceutical industry's sophisticated requirements has reached the market.

Speed and Security are of the Essence

The processing time for the distribution of pharmaceuticals is very short, a dominant feature being fast order cycles. Leading Swiss pharmaceuticals distributor Galexis, for example, accomplishes delivery to a multitude of recipients, with no more than three hours passing between the order being sent electronically by the customer, to delivery at their doorstep.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Andre Grigjanis, Managing Director, Global Competence Centre for IBS Pharma, and John O'Connor, Vice President Global Sales, the IBS Group

Andre Grigjanis is the driving force behind the IBS Group's vertical industry software product, IBS Pharma. During his 10 years as Managing Director of the German subsidiary of IBS (International Business Systems), he has built upon the company's focus on pharmaceutical distribution.

John O'Connor is Vice President Global Sales of the IBS Group, and Area Manager for IBS' operations in Germany and Switzerland. Before joining IBS Group management, he was Managing Director of IBS UK.

spacer
Andre Grigjanis
spacer
spacer
spacer
John O'Connor
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Registration Opens for Inaugural HPAPI USA Conference in October

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
More info >>

White Papers

Clinical Trials in Ukraine: Orange Paper Overview and 1st Half Year 2014

Synergy Research Group

The Orange Paper is an analytical report about the clinical trials market in Russia, published quarterly by the contract research organization Synergy Research Group. The first edition of Orange Paper was released in 2006, and at the moment 31 issues have already published. Now, thanks to Synergy Group Ukraine, obtaining information about the market of clinical trials in Ukraine has become possible. In Ukraine, during the period from 1996 to 2013, applicants had obtained 3,864 positive conclusions about the possibility of conducting clinical trials of drugs, both for domestic and foreign manufacturers, including conduct of multinational multi-center clinical trials (hereinafter MMCTs)
More info >>

 
Industry Events

PDA Europe Annual Meeting 2019

24 June 2019, Hilton Amsterdam

Featuring updates from international regulatory agencies as well as industry, this promises to become another highlight in the 2019 event calendar and is a meeting not to be missed!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement